Gilead Sciences, Inc. et al v. Amneal Pharmaceuticals LLC > Summary
Court Case Number 1:17-cv-00943
Filing Date Jul 13, 2017
Termination Date Jun 8, 2018
Court Delaware District Court
Status Dismissed - Voluntarily
Defendant
Plaintiff Attorneys
8Gilead Sciences
Attorney Name: Christopher P. Borello
Venable
Gilead Sciences
Attorney Name: Brian E. Farnan
Farnan LLP
Gilead Sciences
Attorney Name: Michael J. Farnan
Farnan LLP
Gilead Sciences
Attorney Name: Frederick C. Millett
Venable
Emory University
Attorney Name: Christopher P. Borello
Venable
Emory University
Attorney Name: Brian E. Farnan
Farnan LLP
Emory University
Attorney Name: Michael J. Farnan
Farnan LLP
Emory University
Attorney Name: Frederick C. Millett
Venable
Defendant Attorneys
6Amneal Pharmaceuticals
Attorney Name: Michael R. Dzwonczyk
Sughrue Mion
Amneal Pharmaceuticals
Attorney Name: Anne Shea Gaza
Young Conaway Stargatt & Taylor
Amneal Pharmaceuticals
Attorney Name: Samantha G. Wilson
Young Conaway Stargatt & Taylor
Amneal Pharmaceuticals
Attorney Name: Azadeh S. Kokabi
Sughrue Mion
Attorney Name: Azadeh S. Kokabi
Attorney Name: Aiyda Ghahramani
Cause
35:271 Patent Infringement
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 06703396 | Method of resolution and antiviral activity of 1,3-oxathiolane nuclesoside enantiomers | Mar 9, 2004 |
| 06642245 | Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane | Nov 4, 2003 |
